La Jolla Pharmaceutical Company (NASDAQ:LJPC) (the “Company” or “La Jolla”) a leader in the development of therapeutics targeting significant unmet life-threatening diseases today announced that George Tidmarsh M.D. Ph.D. President and Chief Executive Officer will provide a corporate overview at the 2014 Wedbush Securities Life Sciences Conference taking place August 12-13 in New York City. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) belongs to Healthcare sector. Its net profit margin is value missing and weekly performance is 2.03%. On last trading day company shares ended up $10.05. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) distance from 50-day simple moving average (SMA50) is 5.80%.

Corcept Therapeutics Incorporated (NASDAQ:CORT)’s 2Q2014 was a source of good news even though the company landed a loss. The company reported a loss of 5 cents a share, performing better than 11 cents that analysts expected for the quarter. Its revenue also did not disappoint as it was in-line with the projection at $5.85 million. Corcept Therapeutics Incorporated (NASDAQ:CORT) shares advanced 7.87% in last trading session and ended the day at $2.74. CORT Gross Margin is 97.10% and its return on assets is -75.20%. Corcept Therapeutics Incorporated (NASDAQ:CORT) quarterly performance is 48.11%.

Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ: OMAB; BMV: OMA), announces details for the payment of the remainder of the capital reduction payments that were approved by its shareholders. On 11 August, Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:OMAB) shares advanced 0.90% and was closed at $33.65. OMAB EPS growth in last 5 year was 3.40%. Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:OMAB) year to date (YTD) performance is 30.38%.

Facebook Inc (NASDAQ:FB)’s fight against prosecutors over nearly 400 search warrants for users’ postings and other data is drawing support from other social media companies and civil libertarians. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is -0.10%. On last trading day company shares ended up $73.44. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average (SMA50) is 8.61%.

Elephant Talk Communications Corp. (NYSEMKT:ETAK), a global provider of Software Defined Network Architecture (ET Software DNA® 2.0) platforms and cyber security solutions, today announced that the Company will host its 2014 second quarter financial results conference call on Tuesday, August 12, 2014 at 11:00 a.m. ET. Elephant Talk Communications Corp. (NYSEMKT:ETAK) shares decreased -2.17% in last trading session and ended the day on $0.90. ETAK Gross Margin is 79.70% and its return on assets is -48.10%. Elephant Talk Communications Corp. (NYSEMKT:ETAK) quarterly performance is -14.29%.